Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia

10 Oct 2021

Abstract excerpt

Acquired genetic mutations can confer resistance to arsenic trioxide (ATO) in the treatment of acute promyelocytic leukemia (APL). However, such resistance-conferring mutations are rare and do not explain most disease recurrence seen in the clinic. We have generated stable ATO-resistant promyelocytic cell lines that are less sensitive to all-trans retinoic acid (ATRA) and the combination of ATO and ATRA compared...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Drug-Induced Ocular Toxicity
Share to Retinoids in leukemia and cellular processes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34625794
DOI: 10.1182/bloodadvances.2021005300

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemiaPMID 34625794Read ↗

Arsenic trioxide resistance in acute promyelocytic leukemia: More to it than PML mutationsSemantic proximity Read ↗

Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines.Semantic proximity Read ↗

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemiaSemantic proximity Read ↗

Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.Semantic proximity Read ↗

ATRA Resistance in Acute Promyelocytic Leukemia: Mechanisms Unveiled, Therapies ReimaginedSemantic proximity Read ↗

Molecular Targets of Arsenic Trioxide in Malignant CellsSemantic proximity Read ↗

Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemiaSemantic proximity Read ↗

Mitochondrial metabolism as a target for acute myeloid leukemia treatmentSemantic proximity Read ↗

Alterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myeloma.Semantic proximity Read ↗

Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolismSemantic proximity Read ↗

A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugsSemantic proximity Read ↗

Multi-omic profiling of tyrosine kinase inhibitor-resistant K562 cells suggests metabolic reprogramming to promote cell survivalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.